We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

6 hedge funds and large institutions have $109K invested in China Pharma Holdings in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

0% more funds holding

Funds holding: 6 → 6 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 0.01% → 0% (-0.01%)

74% less capital invested

Capital invested by funds: $422K → $109K (-$313K)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$19.5K
2
VKH
Virtu KCG Holdings
New York
+$8.31K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.49K
4
Renaissance Technologies
Renaissance Technologies
New York
+$337

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$8.08K
2
UBS Group
UBS Group
Switzerland
-$5K
3
PCM
Parsons Capital Management
Rhode Island
-$2K

CPHI Hedge Fund Activity: Q2 2016 in Review

6 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2016, worth a combined $109K — down 74% from $422K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPHI positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $19.5K. The largest seller was Goldman Sachs, cutting an estimated $8.08K.

  • 6 institutional investors held China Pharma Holdings (CPHI) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $109K of China Pharma Holdings stock for Q2 2016, down 74% quarter-over-quarter.
  • 3 funds opened new China Pharma Holdings positions in Q2 2016 and 2 closed out, a net change of +1 holder.
  • The largest China Pharma Holdings buyer in Q2 2016 was Citadel Advisors, an estimated $19.5K added.
  • The largest China Pharma Holdings seller in Q2 2016 was Goldman Sachs, an estimated $8.08K sold.

Based on aggregated 13F filings for Q2 2016.